CU6 2.47% $6.72 clarity pharmaceuticals ltd

CU6 - Media and Industry News, page-417

  1. 171 Posts.
    lightbulb Created with Sketch. 108

    My view on the UBS Report's Clarity related comments!

    Isn’t it a bit ironic that on the one hand, the analysts talk up the Telix pipeline and highlight the potential catalytic effects that some of their candidate products that are still in phase 1 may have, while in the same report, they join in dismissing a competitor on grounds including that they (the competitor) is ‘late’ in the game! This, at at a point when this ‘late’ comer has a candidate product that is in phase 3!


    Does coming in late mean you are going to find nothing left! Will cancers stop developing, now that Telix is in town? If so, why then does Telix even has a thing called a pipeline? A pipeline to what or where, if getting there first is all that matters?

    Perhaps Chris (Telix CEO) was cornered and hadn't had time to prepare, but the Analysts had time to read through all of this!


    Anyway, here is what the Telix CEO said a few months ago in March, when asked about about competition in general (Telix is competing with others), as well as Clarity in particular! Start at 18:40.

    Last edited by ttppxx: Today, 01:01
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
(20min delay)
Last
$6.72
Change
-0.170(2.47%)
Mkt cap ! $2.119B
Open High Low Value Volume
$6.95 $7.25 $6.68 $28.33M 4.127M

Buyers (Bids)

No. Vol. Price($)
1 6509 $6.72
 

Sellers (Offers)

Price($) Vol. No.
$6.78 6841 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.